Yield10 Bioscience, Inc. Stock
Stocks
YTENQ
US98585K8541
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
15:06:39 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 25-10-31 | Yield10 Bioscience, Inc. Went Out of Business | CI |
| 25-10-14 | First Amended Joint Liquidation Plan Approved for Yield10 Bioscience, Inc. | CI |
| Market Cap | 229K 205K 189K 171K 320K 21.75M 326K 2.27M 901K 11.4M 860K 842K 35.93M | P/E 2022 |
-0.6x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 2.34M 2.09M 1.93M 1.75M 3.27M 222M 3.33M 23.22M 9.19M 116M 8.78M 8.59M 367M | EV / Sales 2022 |
14.6x | EV / Sales 2023 | 83x |
| Free-Float |
86% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 17.26 |
| 5 years | 0 | | 210.24 |
| 10 years | 0 | | 8,927.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
CEO | Chief Executive Officer | 68 | 2016-10-16 |
Charles Haaser
DFI | Director of Finance/CFO | 70 | 2014-11-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Oliver Peoples
BRD | Director/Board Member | 68 | 2009-07-06 |
| Chairman | 69 | 2011-11-07 | |
Richard Hamilton
BRD | Director/Board Member | 63 | 2017-03-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/15/24 | Tax | Chief Technology Officer | 877 | 0.1365% | ||
| 8/15/24 | Tax | Chief Financial Officer | 731 | 0.1138% | ||
| 8/15/24 | Tax | Investor Relations Manager | 731 | 0.1138% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 0 | |
| +2.41% | +0.29% | +42.02% | +71.57% | 64.69B | |
| -0.15% | +7.50% | +11.01% | +73.48% | 54.78B | |
| +0.57% | +4.60% | +10.07% | +92.86% | 53.49B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.98B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 42.94B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.08B | |
| +0.05% | +0.21% | +18.26% | +58.53% | 33.52B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.67B | |
| +1.19% | -4.98% | +29.01% | -0.65% | 23.97B | |
| Average | +0.25% | +2.17% | +49.51% | +157.55% | 38.31B | |
| Weighted average by Cap. | +0.39% | +2.73% | +47.57% | +158.58% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 450K 402K 371K 336K 629K 42.72M 640K 4.47M 1.77M 22.38M 1.69M 1.65M 70.56M | 60K 53.58K 49.5K 44.86K 83.92K 5.7M 85.31K 596K 236K 2.98M 225K 220K 9.41M |
| Net income | -13.57M -12.11M -11.19M -10.14M -18.97M -1.29B -19.29M -135M -53.32M -675M -50.91M -49.83M -2.13B | -14.46M -12.91M -11.92M -10.81M -20.22M -1.37B -20.55M -143M -56.81M -719M -54.25M -53.09M -2.27B |
| Net Debt | -1.7M -1.52M -1.4M -1.27M -2.37M -161M -2.41M -16.85M -6.67M -84.4M -6.37M -6.23M -266M | 2.11M 1.88M 1.74M 1.58M 2.95M 200M 3M 20.95M 8.29M 105M 7.92M 7.75M 331M |
Employees
29
| Date | Price | Change | Volume |
|---|
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- YTENQ Stock
Select your edition
All financial news and data tailored to specific country editions
